| Literature DB >> 23124471 |
Xin-Juan Yang1, Fang Miao, Yao Yao, Fang-Jun Cao, Rui Yang, Yan-Ni Ma, Bao-Fu Qin, Le Zhou.
Abstract
In order to understand the antifungal activity of some derivatives of sanguinarine (S) and chelerythrine (C) and their structure-activity relationships, sixteen derivatives of S and C were prepared and evaluated for in vitro antifungal activity against seven phytopathogenic fungi by the mycelial growth rate method. The results showed that S, C and their 6-alkoxy dihydro derivatives S₁-S₄, C₁-C₄ and 6-cyanodihydro derivatives S₅, C₅ showed significant antifungal activity at 100 µg/mL against all the tested fungi. For most tested fungi, the median effective concentrations of S, S₁, C and C₁ were in a range of 14-50 µg/mL. The structure-activity relationship showed that the C=N+ moiety was the determinant for the antifungal activity of S and C. S₁-S₅ and C₁-C₅ could be considered as the precursors of S and C, respectively. Thus, the present results strongly suggested that S and C or their derivatives S₁-S₅ and C₁-C₅ should be considered as good lead compounds or model molecules to develop new anti-phytopathogenic fungal agents. can't login to work station for 2hrs--took 2 hrs vacationEntities:
Mesh:
Substances:
Year: 2012 PMID: 23124471 PMCID: PMC6268840 DOI: 10.3390/molecules171113026
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of sanguinarine (S) and chelerythrine (C).
Figure 2Derivatives of sanguinarine S and chelerythrine C.
Scheme 1Synthetic pathway for compounds S and C.
Linear Growth inhibitory rates (means ± S.D.%) of 18 compounds against seven phytopathogenic fungi (100 µg/mL).
| Compd. | Seven Tested Phytopathogenic Fungi * | ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 19.1 ± 2.0HI | −4.0 ± 3.5FG | −0.1 ± 3.2F | −0.5 ± 0.9K | −4.4 ± 0.9J | 9.7 ± 1.2HI | 16.2 ± 1.5H |
|
| 33.0 ± 1.3F | −8.3 ± 1.7H | 7.5 ± 1.9E | 2.0 ± 3.4JK | −0.1 ± 1.8HI | 20.8 ± 0.0G | 21.2 ± 0.9G |
|
| 18.0 ± 1.3I | 3.4 ± 0.7DE | 6.3 ± 0.7E | 0.5 ± 0.9JK | 2.6 ± 3.9H | 5.8 ± 1.2IJ | 11.0 ± 1.5I |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5.7 ± 3.4J | −1.4 ± 2.8EF | 8.6 ± 3.9E | 5.0 ± 0.9IJ | −3.3 ± 3.3IJ | 1.4 ± 2.4J | 5.5 ± 1.5J |
|
| 18.0 ± 1.3I | 5.1 ± 6.9D | 10.5 ± 3.2E | 13.4 ± 0.0H | 12.7 ± 2.4F | 28.9 ± 5.9F | 47.9 ± 5.9E |
|
| 24.0 ± 2.0GH | −5.2 ± 2.4FG | 10.5 ± 1.3E | 9.5 ± 4.8HI | 6.8 ± 0.9G | 11.9 ± 1.3H | 24.7 ± 1.8G |
| TBZ *** | 27.1 ± 1.5G | 88.4 ± 0.8AB | 83.9 ± 3.5BC | 100.0 ± 0.0A | 100.0 ± 0.0A | 15.3 ± 6.7GH | 30.6 ± 4.0F |
* C.L.: Curvularia lunata; V.M.: Valsa mali; F.S.: Fusarium solani; F.O.V.: Fusarium oxysporum f. sp. vasinfectum; A.A.: Alternaria alternate; P.O.: Pyricularia oryza; F.O.N.: Fusarium oxysporum sp. niveum. ** The differences between data with different capital letters within a column are significant for the same tested fungus (p < 0.01) with respect to S and its pseudoalcoholates or C and its pseudoalcoholates. *** TBZ: thiabendazole.
Toxicity regression equations and EC50 values of compounds S, C, S and C against seven fungi.
| Fungus | Compd. | Toxicity regression equation * |
| EC50 value | CI 95% ** (µg/mL) | CA *** | |
|---|---|---|---|---|---|---|---|
| (µg/mL) | (µM) | ||||||
| C.L. | S | 0.9628 | 35.20 | 76.6 | 35.13–35.27 | 16.4 | |
| S1 | 0.9848 | 28.84 | 79.4 | 28.81–28.85 | 18.9 | ||
| C | 0.9621 | 15.43 | 32.5 | 15.21–15.65 | 22.1 | ||
| C1 | 0.9914 | 14.23 | 37.5 | 14.18–14.28 | 25.5 | ||
| V.M. | S | 0.9901 | 24.28 | 52.9 | 24.24–24.32 | 26.0 | |
| S1 | 0.9860 | 24.51 | 67.5 | 23.97–25.05 | 21.5 | ||
| C | 0.9505 | 39.40 | 82.9 | 39.30–39.50 | 17.6 | ||
| C1 | 0.9904 | 29.36 | 77.4 | 29.34–29.38 | 21.9 | ||
| F.S. | S | 0.9717 | 40.53 | 88.3 | 40.46–40.60 | 18.3 | |
| S1 | 0.957 | 35.04 | 96.4 | 34.95–35.13 | 17.0 | ||
| C | 0.9600 | 26.50 | 55.8 | 26.41–26.59 | 18.9 | ||
| C1 | 0.9925 | 27.26 | 71.8 | 27.24–27.28 | 21.8 | ||
| F.O.N. | S | 0.9768 | 48.79 | 106.2 | 48.73–48.85 | 10.9 | |
| S1 | 0.9705 | 32.79 | 90.2 | 32.73–32.85 | 16.7 | ||
| C | 0.9891 | 29.32 | 61.7 | 29.30–29.34 | 21.1 | ||
| C1 | 0.9836 | 28.30 | 74.6 | 28.26–28.34 | 23.4 | ||
| F.O.V. | S | 0.9735 | 33.20 | 72.3 | 33.14–33.26 | 18.1 | |
| S1 | 0.9826 | 34.70 | 95.5 | 34.66–34.74 | 18.2 | ||
| C | 0.9600 | 51.84 | 109.1 | 51.80–51.88 | 19.9 | ||
| C1 | 0.9684 | 29.98 | 79.0 | 29.91–30.06 | 21.0 | ||
| P.O. | S | 0.9687 | 101.6 | 221.2 | 101.2–102.00 | 3.1 | |
| S1 | 0.9914 | 96.63 | 265.9 | 96.61-96.63 | 4.4 | ||
| C | 0.9727 | 48.44 | 101.9 | 48.41–48.47 | 15.4 | ||
| C1 | 0.9843 | 43.75 | 115.3 | 43.72–43.78 | 16.4 | ||
| A.A. | S | 0.9608 | 53.08 | 115.6 | 53.03–53.13 | 14.9 | |
| S1 | 0.9193 | 43.47 | 119.6 | 43.10–43.84 | 11.9 | ||
| C | 0.9572 | 50.08 | 105.4 | 50.03–50.13 | 18.5 | ||
| C1 | 0.9659 | 29.11 | 76.7 | 29.04–29.18 | 21.4 | ||
* y: Inhibitory rate. x: Log10[concentration(mg/L)]; ** CI 95%: Confidence interval at 95% probability (µg/mL). *** Slope value/EC50 (μg/mL) × 1,000.